Initial medical work-up of first-episode psychosis: A conceptual review

Early Intervention in Psychiatry

Volumn 3, Issue 1, 2009, Pages 10-18

  Freudenreich, Oliver ^a,b   Charles Schulz, S ^c   Goff, Donald C ^a,b  

^a Freedom Trail Clinic   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

First episode psychosis; Medical work up; Secondary schizophrenia

Indexed keywords

ANTINUCLEAR ANTIBODY;

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; EPIDEMIOLOGICAL DATA; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; HUMAN; LABORATORY TEST; MEDICAL ASSESSMENT; MENTAL PERFORMANCE; NEUROIMAGING; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

BRAIN; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES AS TOPIC; SCHIZOPHRENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 64949146706     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2008.00105.x     Document Type: Review

References (43)

1. Yung AR, Killackey E, Hetrick SE et al. The prevention of schizophrenia. Int Rev Psychiatry 2007; 19: 633-46.
2. Gaebel W, Weinmann S, Sartorius N et al. Schizophrenia practice guidelines: International survey and comparison. Br J Psychiatry 2005; 187: 248-55.
3. Lehman AF, Lieberman JA, Dixon LB et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004; 161 (Suppl. 2): 1-56.
4. Canadian Psychiatric Association. Clinical Practice Guidelines. Treatment of Schizophrenia. Can J Psychiatry 2005; 50 (Suppl. 1): 1S-56S.
5. McGorry P, Killackey E, Elkins K et al. Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia. Australas Psychiatry 2003; 11: 136-47.
6. Perkins DO, Gu H, Boteva K et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
7. Marshall M, Lewis S, Lockwood A et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry 2005; 62: 975-83.
8. Freudenreich O, Holt DJ, Cather C et al. The evaluation and management of patients with first episode schizophrenia. A selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry 2007; 15: 189-211.
9. Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S et al. Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry 2006; 163: 1349-54.
10. Chemerinski E, Robinson RG. The neuropsychiatry of stroke. Psychosomatics 2000; 41: 5-14.
11. Walterfang M, Fietz M, Fahey M et al. The neuropsychiatry of Niemann-Pick type C in adulthood. J Neuropsychiatry Clin Neurosci 2006; 18: 158-70.
12. MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 1998; 10: 10-19.
13. Sabin TD, Jednacz JA, Staats PN. Case 26-2008: A 26-year-old woman with headache and behavioral changes. N Engl J Med 2008; 359: 842-53.
14. Nasky KM, Knittel DR, Manos GH. Psychosis associated with anti-N-methyl-D-aspartate receptor antibodies. CNS Spectr 2008; 13: 699-702.
15. Johnstone EC, Macmillan JF, Crow TJ. The occurrence of organic disease of possible or probably aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med 1987; 17: 371-9.
16. Baldessarini RJ, Finklestein S, Arana GW. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry 1983; 40: 569-73.
17. Slater E, Beard AW. The schizophrenia-like psychoses of epilepsy. V. Discussion and conclusions. Br J Psychiatry 1963; 109: 143-50.
18. Sackett DL. Clinical epidemiology: What, who, and whither. J Clin Epidemiol 2002; 55: 1161-6.
19. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996; 77: 834-42.
20. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502-8.
21. Leucht S, Burkard T, Henderson J et al. Physical illness and schizophrenia: A review of the literature. Acta Psychiat Scand 2007; 116: 317-33.
22. Coleman M, Gillberg C. A biological approach to the schizophrenia spectrum disorders. J Neuropsychiatry Clin Neurosci 1997; 9: 601-5.
23. Golomb M. Psychiatric symptoms in metabolic and other genetic disorders: is our 'organic'workup complete? Harv Rev Psychiatry 2002; 10: 242-8.
24. Coleman M, Gillberg C. The Schizophrenias. A Biological Approach to the Schizophrenia Spectrum Disorders. New York, NY: Springer Publishing Company, 1996.
25. Branson BM, Handsfield HH, Lampe MA et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55 (RR 14): 1-17.
26. Lair L, Naidech AM. Modern neuropsychiatric presentation of neurosyphilis. Neurology 2004; 63: 1331-3.
27. Horowitz A, Shifman S, Rivlin N et al. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 2005; 73: 263-7.
28. Nicolson R, Giedd JN, Lenane M et al. Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. Am J Psychiatry 1999; 156: 1575-779.
29. Salinsky M, Kanter R, Dasheiff RM. Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: An operational curve. Epilepsia 1987; 28: 331-4.
30. Manchanda R, Norman R, Malla A et al. EEG abnormalities and two year outcome in first episode psychosis. Acta Psychiatr Scand 2005; 111: 208-13.
31. Manchanda R, Norman R, Malla A et al. EEG abnormalities and 3-year outcome in first episode psychosis. Acta Psychiat Scand 2008; 117: 277-82.
32. Freudenreich O, Weiner RD, McEvoy JP. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 1997; 42: 132-7.
33. Douglass AB, Hays P, Pazderka F et al. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 1991; 179: 12-17.
34. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999; 282: 36-9.
35. Lubman DI, Velakoulis D, McGorry PD et al. Incidental radiological findings on brain magnetic resonance imaging in first-episode psychosis and chronic schizophrenia. Acta Psychiatr Scand 2002; 106: 331-6.
36. Bain BK. CT scans of first-break psychotic patients in good general health. Psychiatr Serv 1998; 49: 234-5.
37. Gewirtz G, Squires-Wheeler E, Sharif Z et al. Results of computerised tomography during first admission for psychosis. Br J Psychiatry 1994; 164: 789-95.
38. Walterfang M, Wood SJ, Velakoulis D et al. Diseases of white matter and schizophrenia-like psychosis. Aust N Z J Psychiatry 2005; 39: 746-56.
39. Marder SR, Essock SM, Miller AL et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334-49.
40. Goff DC, Cather C, Evins AE et al. Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists. J Clin Psychiatry 2005; 66: 183-94.
41. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596-601.
42. Citrome L. Current guidelines and their recommendations for prolactin monitoring in psychosis. J Psychopharmacol 2008; 22 (Suppl. 2): 90-7.
43. Goff DC. Integrating general health care in private community psychiatry practice. J Clin Psychiatry 2007; 68 (Suppl. 4): 49-54.